Avaleht › Depressioon › Washington
Depressioon kliinilised uuringud osariigis Washington
21 uuringut haiguse Depressioon jaoks otsivad osalejaid osariigis Washington.
Linnad osariigis Washington
Ametlik uuringutekst (inglise keeles)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 1. okt 2026 · NCT07775300A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
VärbamineFaas 3
Vanused 18–85 · Kõik sood · Uuendatud 25. sept 2026 · NCT06793397RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Seattle Neuropsychiatric Treatment Center, Seattle
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 15. sept 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 14. sept 2026 · NCT07065240PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
- Seattle NTC, Seattle
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06713616A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. sept 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 26. aug 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 14. aug 2026 · NCT07226232A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 6. aug 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale
VärbamineFaas 3
Vanused 18–50 · Kõik sood · Uuendatud 4. aug 2026 · NCT06748222A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Core Clinical Research, Everett
VärbamineFaas 3
Vanused 18–74 · Kõik sood · Uuendatud 3. aug 2026 · NCT06775379A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Core Clinical Research /ID# 226374, Everett
VärbamineFaas 3
Vanused 10–17 · Kõik sood · Uuendatud 27. juuli 2026 · NCT04777357Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. juuli 2026 · NCT06966401CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Madigan Army Medical Center, Fort Lewis
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. juuli 2026 · NCT05663034TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
- Seattle Children's Hospital, Seattle
VärbamineVaatlusuuring
18 Months – 11 Years · Kõik sood · Uuendatud 6. juuli 2026 · NCT07048574A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Center For Anxiety and Depression, Mercer Island
- Seattle Neuropsychiatric Treatment Center, Seattle
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 15. juuni 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Seattle Neuropsychiatric Treatment Center, Bellevue
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 11. mai 2026 · NCT06524830Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- Seattle Children's Hospital, Seattle
Värbamine
Vanused 12–22 · Kõik sood · Uuendatud 30. okt 2025 · NCT06232304Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. okt 2025 · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
VärbamineFaas 4
Vanused 18–65 · Kõik sood · Uuendatud 23. jaan 2025 · NCT06223880Lay-Delivered Behavioral Activation in Senior Centers
- Enumclaw Senior Center, Enumclaw
- Casa Latina, Seattle
- Centro de la Raza, Seattle
- ja veel 1
Värbamine
Vanused 60 ja vanemad · Kõik sood · Uuendatud 15. okt 2024 · NCT04621877Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.